All Articles
Browse every published article, from the latest research to earlier analysis. Use the page numbers below to explore the complete archive.
Clonazepam and Sleep Behaviors in Two Sisters With Hyperekplexia
A two-sibling report described improved startles and sleep-related motor activity with clonazepam in a rare genetic disorder.
Milk Peptide and Diazepam Comparisons: Similar Mouse Behavior Did Not Mean Identical Neural Patterns
A mouse experiment found anxiolytic-like behavioral effects of a casein-derived peptide alongside brain-marker patterns that differed from diazepam.
Midazolam Brain Connectivity Findings Changed With fMRI Processing Choices
A crossover imaging study found that preprocessing decisions affected estimated midazolam-related functional connectivity changes.
Calycosin Rat Study: Midazolam Was a Null Finding Among Several Probe Drugs
A cocktail pharmacokinetic study found no significant midazolam difference after the tested calycosin treatments.
Midazolam as a CYP3A Probe Did Not Closely Predict Fentanyl Clearance in This Small Study
A palliative-care study found only a weak relationship between midazolam-based CYP3A activity and estimated fentanyl clearance.
Midazolam in a Conditional Mouse Model: Separating Liver and Intestinal Metabolism
A genetically engineered mouse model used midazolam to investigate the separate contributions of liver and intestinal oxidative metabolism.
Obese ICU Patients and Midazolam: Why Surgical Pharmacokinetic Data Need Caution
A critical-care review highlights the evidence gap between small obesity pharmacokinetic studies and dosing decisions in unstable ICU patients.
Lorazepam Rescue in a Cancer Delirium Trial: An Allowed Treatment Is Not a Randomized Comparison
A trial comparing olanzapine with haloperidol allowed individualized lorazepam rescue, so it cannot determine lorazepam’s independent efficacy.
ADHD Treatment During Opioid Agonist Therapy: Concomitant Sedative Dispensing Needs Detail
A Norwegian registry study found frequent additional potentially addictive drug dispensing among patients receiving both ADHD medication and opioid agonist therapy.
Prescription Overlap Surveillance: Benzodiazepine Dispensing Is an Exposure Proxy
An eleven-state surveillance report shows how prescription data can track opioid-benzodiazepine overlap while leaving actual ingestion uncertain.
Age and Benzodiazepine Misuse: Motives Should Not Be Assumed From a Drug Result
A lifespan review describes age-related differences in prescription misuse while emphasizing particularly limited benzodiazepine-specific longitudinal evidence.
Swiss Primary Care Prescribing: Benzodiazepines Among a Small Group of Common Review Targets
A Swiss study found potentially inappropriate prescriptions concentrated in several familiar medication classes, including benzodiazepines.
Bronchoscopy Stimulation Trial: Less Cough Did Not Mean Less Midazolam
A randomized bronchoscopy study reported lower cough scores with electrical acupoint stimulation but no significant reduction in midazolam dosage.
Flumazenil in Mixed Poisoning: Why Reversing Sedation Is a Narrow Endpoint
A poisoning review distinguishes reversal of benzodiazepine sedation from reliable correction of all consequences of an overdose.
Japanese Emergency Psychiatry Study: Benzodiazepine Route Reflects Treatment Selection
A nine-department naturalistic study documented markedly different intramuscular and intravenous medication choices during psychiatric emergencies.
Benzodiazepine Seizure Rescue When Ventilatory Support Is Limited
A review of pediatric acute seizure care explains why respiratory support capacity affects how seizure treatment recommendations are applied.
Dexmedetomidine Pediatric-Weaning Paper Was a Trial Protocol Rather Than Evidence of Proven Withdrawal Prevention
A multicenter protocol proposed testing dexmedetomidine against placebo. The planned sample size and dosing schedule were methods, not completed safety or efficacy findings.
REM Sleep Behavior Cohort Associated Depression With Poorer Response to Clonazepam or Melatonin
A record review found that depression marked a lower likelihood of symptom improvement. The combined treatment endpoint did not isolate clonazepam’s independent efficacy.
Liver-Transplant Catatonia Cases Responded to Lorazepam Without Proving Immunosuppressant Toxicity
Two reports described rapid response to intravenous lorazepam after transplantation. Treatment response supported a clinical syndrome while leaving its cause uncertain.
Endoscopy Meta-Analysis Found Safety and Recovery Results Depended on the Sedation Comparison
A review pooled propofol against several traditional and combined regimens. Its grouped results did not support one undifferentiated claim that propofol always improves recovery or safety.
Repeated-Ketamine Trial’s Final Comparison Included Ketamine in Both Groups After Midazolam Control Infusions
A randomized trial’s earlier and final comparisons answered different questions. Midazolam controls were followed by ketamine in one group, changing the meaning of the primary endpoint.
Deprescribing Policy Review Found That Reduced Sedative Prescribing Could Be Accompanied by Substitution
An international policy review considered both intended and unintended consequences. Fewer prescriptions for one product did not necessarily mean less overall sedative harm.
Controlled-Substance Renewal Study Grouped Nonprescribed Opioid and Benzodiazepine Results in One Comparison
A practice review described prescription decisions after urine testing. The reported renewal rates did not demonstrate the clinical safety or appropriateness of those decisions.
Infusion-Tubing Experiment Found Diazepam Loss Varied With Material Rather Than Improving With Every PVC Alternative
A laboratory study showed that alternative infusion materials had different effects on drug recovery. A broad material category did not guarantee less diazepam sorption.
Darolutamide Study Showed That a Large Statin Interaction Did Not Predict an Equally Large Midazolam Effect
A drug-interaction program examined enzymes and transporters with different probes. Its strongest clinical exposure change involved a transporter substrate, not every tested medicine.
Upadacitinib Cocktail Study Measured a Twenty-Six-Percent Reduction in Midazolam Exposure
A healthy-volunteer study found a modest exposure change with repeated upadacitinib. The result concerned a particular dose and schedule, rather than a universal effect across benzodiazepines.
Norwegian Opioid-Treatment Study Found No Association Between Recent Benzodiazepine Use and Lifetime Suicide Attempts
A study reported frequent lifetime suicide attempts but no crude association with recent benzodiazepine use. Its different exposure and outcome time windows constrain interpretation.
SGCE Myoclonus–Dystonia Case Reported Clonazepam Nonresponse Despite Preserved Development
A genetic movement-disorder case separated symptom persistence from broader developmental outcome. Lack of medication response did not imply progressive global impairment.
Korean Pain Cohort Linked Benzodiazepine or Z-Drug Use With Long-Term Opioid Prescribing
A longitudinal administrative study found that sedative-hypnotic use marked a population more likely to receive long-term opioids. Its mortality result concerned a different exposure comparison.
Pediatric Lithotripsy Series Used Diazepam–Ketamine Sedation While Studying Stone-Clearance Factors
A procedural series reported stone outcomes under a combined sedation approach. Stone clearance did not measure diazepam’s independent efficacy or safety.